CClinicalTrials.gg
CompletedNCT01748214Updated Dec 12, 2012

Premature Infant Exposure to Noise Generated by Respiratory Support

An observational study in Premature Birth of Newborn, sponsored by University of Virginia. Completed at 1 site in United States. Open to participants aged 7 Days and older. Per ClinicalTrials.gov, last updated 2012-12-12.

Sponsored by University of Virginia · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
28
Ages
7 Days and older
Sex
All
01

Study summary

Infants in neonatal intensive care units are increasing exposed to non-invasive ventilatory support modes (nasal continuous positive airway pressure - NCPAP and high flow nasal cannula: >1 L/min flow - HFNC). While there have been small descriptive studies of noise exposure in infants on NCPAP, there have been no comparative trials done comparing noise exposure in infants undergoing both NCPAP and HFNC.

Objective: Using a cross-over model determine noise exposure levels in infants exposed to similar levels of respiratory support provided by NCPAP and HFNC.

Read the detailed description

Infants born \< 32 weeks, in an incubator, and > 7 days postnatal that were maintained on either on NCPAP or HFNC to maintain SaO2 in a range of 88 - 92 %. Study infants had decibel measurements obtained every 15 seconds for 30 minutes using a noise dosimeter (NoisePro DLX-1). The microphone for the dosimeter was suspended from the inside of the incubator such that it hung 1 foot above the infants nose and mouth. The exhalation port for NCPAP was placed outside of the incubator. Repeated measurement periods on the same mode of support were made within a 72 hour period. Each infant the acted as their own control and was switched within 7 days to the alternative respiratory support method that maintained similar SaO2 goals and repeat measurements were obtained. Comparisons of mean decibel levels during recording were compared using paired t-tests.

02

Conditions studied

  • Premature Birth of Newborn

Browse trials for

Keywords

  • continuous positive airway pressure
  • high flow nasal cannula
  • hearing outcomes
  • noise exposure
  • preterm infants
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 28 is below the median of 112 across 777 observational studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University of Virginia is the lead sponsor of 653 studies on the registry; 134 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 41 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Days and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Infants born \< 32 weeks, in an incubator, and > 7 days postnatal admitted to the Newborn Intensive Care Unit

Inclusion criteria

  • Premature infant born \< 32 weeks and 0 days post-conceptional age;
  • Seven or more days of age and not in acute respiratory distress;
  • Need for nasal continuous positive airway pressure or high-flow nasal cannula for ventilation or supplemental oxygen delivery;
  • In a neutral-thermal environment (i.e. isolette)

Exclusion criteria

Exclusion Criteria:

  • Oro-facial congenital anomalies;
  • Congenital heart disease (except for patent ductus arteriosus and/or patent foramen ovale);
  • Unstable respiratory status as deemed by the attending physician
  • Patients under isolation for infectious disease
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
28 participants (actual)

Groups and cohorts

  • Nasal CPAP

    Infants received nasal CPAP as standard of care.

  • High Flow Nasal Cannual

    Infants received high flow nasal cannula as standard of care.

06

What researchers measure

Primary outcomes

  1. Noise level

    Noise levels will be measured during a set time while infants are on Nasal CPAP and Nasal High flow cannula as standard of care

    Time frame: 6 days

07

Study locations

1 site
  • University of Virginia Health System
    Charlottesville, Virginia 22908, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01748214
Lead sponsor
University of Virginia
Responsible party
Jonathan Swanson, MD (Prinicipal Investigator, University of Virginia) — Principal investigator
First posted
Dec 12, 2012
Start date
Nov 2008
Primary completion
Nov 2010
Completion
Nov 2010
Last update
Dec 12, 2012

Study contacts

Joshua Attridge, MD
principal investigator · UVA School of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion